2021
Novel antibody-drug conjugates: current and future roles in gynecologic oncology.
Current opinion in obstetrics & gynecology
鈥�Research at a glance
Top areas of exploration
- Pregnancy , 14 publications
- Cell Line, Tumor , 10 publications
- Uterine Neoplasms , 8 publications
- Neoplasm Recurrence, Local , 7 publications
Research activity
My publications
Filter publications
81 publications
2021
Novel mesothelin antibody-drug conjugates: current evidence and future role in the treatment of ovarian cancer.
Expert opinion on biological therapy
鈥�2021
Trastuzumab tolerability in the treatment of advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress HER2/neu.
Gynecologic oncology
鈥�2020
Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan.
Scientific reports
鈥�2020
Comparison of the long-term impact and clinical outcomes of fewer doses and standard doses of human papillomavirus vaccine in the United States: A database study.
Cancer
鈥�